MediciNova, Inc.

Healthcare

NASDAQ:MNOV · NASDAQ Global Market

Market Cap $65.96M Beta 0.62 P/E (TTM) -5.6

$1.32 -1.32%

-$0.02 today

52W Low $1.17High $1.96

Vol 0.03M · Avg 0.04M

EPS (TTM) -$0.24Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+0.76%

Period High

$1.88

Period Low

$1.18

Latest

$1.32

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Relmada Therapeutics, Inc.

NASDAQ:RLMD

$485.48M

Immunic, Inc.

NASDAQ:IMUX

$139.25M

Vaxart, Inc.

NASDAQ:VXRT

$133.12M

Fortress Biotech, Inc.

NASDAQ:FBIO

$100.82M

XBiotech Inc.

NASDAQ:XBIT

$71.65M

Biomea Fusion, Inc.

NASDAQ:BMEA

$69.59M

PMV Pharmaceuticals, Inc.

NASDAQ:PMVP

$60.53M

Cibus, Inc.

NASDAQ:CBUS

$59.82M

TScan Therapeutics, Inc.

NASDAQ:TCRX

$55.82M

Acrivon Therapeutics, Inc. Common Stock

ACRV

$48.75M

What is the latest MNOV filing?

The latest filing shown is 10-Q dated May 14, 2026.

How many recent filings does MNOV have?

Intrinsic Alpha currently shows 20 recent filings for MNOV.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.